Occipital stroke shortly after cannabis consumption

Finsterer, Josef; Prainer, Christian; Kopsa, Wolfgang

doi:10.1016/j.clineuro.2004.02.001

Cited by 45 publications

(25 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…16,21,28,38 Furthermore, in other cases, strokes have occurred up to half an hour after the last joint has been smoked. 12,16,20,25,27 These results are in accordance with one large study showing that cannabis increases myocardial infarction 4.8-fold during the hour following its intake. 44 In a review …”

Section: Neurological Complications Of Cannabis Abusesupporting

confidence: 81%

“…In the literature, 59 case reports of cannabis-related stroke (mean age, 33±12.4 years) were described, and among them there was a majority of men with a sex ratio of 4.9:1. Most of stroke were IS (n=49) 11,12,[14][15][16][17][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37] or transient ischemic attacks (n=5). 14,38,39 There is only 1 patient who was described with an hemorrhagic stroke associated with cannabis use.…”

Section: Neurological Complications Of Cannabis Abusementioning

confidence: 99%

See 1 more Smart Citation

Cannabis-related Stroke

Wolff

Armspach

Lauer

et al. 2013

Stroke

113

View full text Add to dashboard Cite

Section: Neurological Complications Of Cannabis Abusesupporting

confidence: 81%

Section: Neurological Complications Of Cannabis Abusementioning

confidence: 99%

Cannabis-related Stroke

Wolff

Armspach

Lauer

et al. 2013

Stroke

113

View full text Add to dashboard Cite

“…Transient ischemic attacks (51) and cerebrovascular stroke, usually following acute cannabis use, have also been reported in several case reports (52)(53)(54)(55)(56). Renal infarction following cannabis smoking has also been reported (57).…”

Section: Acute Effectsmentioning

confidence: 92%

Safety Issues Concerning the Medical Use of Cannabis and Cannabinoids

Ware

Tawfik

2005

Pain Research and Management

View full text Add to dashboard Cite

Safety issues are a major barrier to the use of cannabis and cannabinoid medications for clinical purposes. Information on the safety of herbal cannabis may be derived from studies of recreational cannabis use, but cannabis exposure and effects may differ widely between medical and recreational cannabis users. Standardized, quality-controlled cannabinoid products are available in Canada, and safety profiles of approved medications are available through the Canadian formulary. In the present article, the evidence behind major safety issues related to cannabis use is summarized, with the aim of promoting informed dialogue between physicians and patients in whom cannabinoid therapy is being considered. Caution is advised in interpreting these data, because clinical experience with cannabinoid use is in the early stages. There is a need for long-term safety monitoring of patients using cannabinoids for a wide variety of conditions, to further guide therapeutic decisions and public policy.

show abstract

“…[6,11,12] Long-term use of marijuana in young people may cause serious damage to the cerebrovascular system, and toxicological screening should be done if necessary. Moreover, marijuana abuse causes systemic hypertension and damage of vasomotor reflexes and the central nervous system.…”

Section: Discussionmentioning

confidence: 99%